In vivocharacterization of brain metabolism by1H MRS,13C MRS and18FDG PET reveals significant glucose oxidation of invasively growing glioma cells
Autor: | Carole Poitry-Yamate, Monika E. Hegi, Bernard Lanz, Marie-France Hamou, Cristina Cudalbu, Rolf Gruetter, Irene Vassallo, Marta Lai |
---|---|
Rok vydání: | 2018 |
Předmět: |
In vivo magnetic resonance spectroscopy
Cancer Research Tumor suppressor gene Chemistry Glutamate receptor Carbohydrate metabolism FDG-Positron Emission Tomography medicine.disease 03 medical and health sciences 0302 clinical medicine Oncology In vivo 030220 oncology & carcinogenesis Glioma medicine Cancer research Glycolysis 030217 neurology & neurosurgery |
Zdroj: | International Journal of Cancer. 143:127-138 |
ISSN: | 0020-7136 |
Popis: | Glioblastoma are notorious for their highly invasive growth, diffusely infiltrating adjacent brain structures that precludes complete resection, and is a major obstacle for cure. To characterize this "invisible" tumor part, we designed a high resolution multimodal imaging approach assessing in vivo the metabolism of invasively growing glioma xenografts in the mouse brain. Animals were subjected longitudinally to magnetic resonance imaging (MRI) and 1 H spectroscopy (MRS) at ultra high field (14.1 Tesla) that allowed the measurement of 16 metabolic biomarkers to characterize the metabolic profiles. As expected, the neuronal functionality was progressively compromised as indicated by decreasing N-acetyl aspartate, glutamate and gamma-aminobutyric acid and reduced neuronal TCA cycle (-58%) and neurotransmission (-50%). The dynamic metabolic changes observed, captured differences in invasive growth that was modulated by re-expression of the tumor suppressor gene WNT inhibitory factor 1 (WIF1) in the orthotopic xenografts that attenuates invasion. At late stage mice were subjected to 13 C MRS with infusion of [1,6-13 C]glucose and 18 FDG positron emission tomography (PET) to quantify cell-specific metabolic fluxes involved in glucose metabolism. Most interestingly, this provided the first in vivo evidence for significant glucose oxidation in glioma cells. This suggests that the infiltrative front of glioma does not undergo the glycolytic switch per se, but that environmental triggers may induce metabolic reprograming of tumor cells. |
Databáze: | OpenAIRE |
Externí odkaz: |